Phase II Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men.
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2013
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 02 Aug 2011 Actual end date Aug 2009 added as reported by ClinicalTrials.gov.
- 02 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2011 Results presented at the 18th Conference on Retroviruses and Opportunistic Infections.